Biosimilars are an opportunity to help reduce the burden of rising treatment costs.

Diversity drives innovation, which in turn drives change and progress.

At Sandoz our work is focused on improving access to medicines, access to medical information and access ...

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Explore Novartis

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.